Mt. Hood. IOM Report: 10 Years After & More Coming Mitch Greenlick, Ph.D. Oregon State Representative April 21, 2010.

Slides:



Advertisements
Similar presentations
Moving the process forward Sálvano Briceño UN/ISDR.
Advertisements

CARMEN Policy Observatory and Dialogue Proposal Presentation to the CARMEN Directing Board Meeting San Juan, Puerto Rico 30 June 2003.
©PPRNet 2014 Impact of Patient Engagement on Treatment Decisions and Patient-Centered Outcomes in the Implementation of New Guidelines for the Treatment.
Engaging Patients and Other Stakeholders in Clinical Research
Phase O Trials: Ethical Considerations Holly Taylor, PhD, MPH Department of Health Policy and Management Bloomberg School of Public Health Berman Institute.
Introduction to the User’s Guide for Developing a Protocol for Observational Comparative Effectiveness Research Prepared for: Agency for Healthcare Research.
What factors from the outside environment do you think will be important to AMDA’s future success?  Movement to evidence-based medicine  Emerging models.
Comparative Effectiveness Research in the National Drug Abuse Treatment Clinical Trials Network (CTN) CDR Steven Sparenborg, Ph.D., Udi Ghitza, Ph.D.,
Learning Health System Challenge and Planning Awards Alexander K. Ommaya, DSc Sr. Dir. Clinical Effectiveness & Implementation Research Philip M. Alberti,
Health Line of Business Revised Health Domains January 26, 2005 Outcomes / Domains have been revised.
Oakland University William Beaumont School of Medicine.
Dorota Kilańska RN, PhD European Nursing Research Foundation (ENRF)
Virginia Li - Photovoice - 10 Nov 2008 Photovoice: Beyond Visual Anthropology Caroline Wang, DrPH, Program Director Public Health Institute, Berkley, California.
Stakeholder Engagement and Transparency in The Effective Health Care Program Supriya Janakiraman MD MPH AHRQ.
TYPE 2 TRANSLATIONAL RESEARCH 2009 GRANT PROGRAMS UW Institute for Clinical and Translational Research (ICTR) Community-Academic Partnership Core (CAP)
Strategic Plan Evidence, knowledge and action for a healthier Ontario October 2, 2013 Presentation to ANDSOOHA.
Access to Clinical Expertise Steve Bain David Powell Jemma Hughes Paula Jeffries.
The Transformation Center Helping Good Ideas Travel Faster Cathy Kaufmann, MSW Executive Director, OHA Transformation Center.
NIDA/SAMHSA Blending Initiative Overview. Advances in science are giving us a broad range of promising options for treating substance use disorders, BUT.
Chartered Value Exchanges (CVEs) September 2008 CVEs may wish to tailor this slide deck for use with stakeholders in your community.
Engaging Stakeholders in the Effective Health Care Program Information and tools for researchers and investigators.
Digital Town Square A place-based approach to health information management.
Transboundary Conservation Governance: Key Principles & Concepts Governance of Transboundary Conservation Areas WPC, Sydney, 17 November 2014 Matthew McKinney.
Harold I Perl, PhD Center for the Clinical Trials Network National Institute on Drug Abuse NIATx Summit and SAAS National Conference Boston, MA July 13,
2010 NIAMS Scientific Retreat Comparative Effectiveness Research Institute of Medicine Priorities Functional Limitations & Disabilities Endocrinology &
Joe Selby, MD MPH EBRI December 15, 2011 What Might Patient (Employee)- Centered Research Look Like?
Implementation Science and the Adoption of Practice in Addiction Treatment Harold I Perl, PhD Center for the Clinical Trials Network National Institute.
KENTUCKY YOUTH FIRST Grant Period August July
The European Network for Patient Safety & Quality JA PaSQ International Forum on Quality & Safety in Healthcare Paris, 10 April 2014 J.Bacou, HAS PaSQ.
ACCELERATING CLINICAL AND TRANSLATIONAL RESEARCH
West Virginia Clinical Translational Science Institute Links Scientists and Teachers Sara Hanks, Ann Chester, Summer Kuhn.
A Model for Translating Research into Practice in the United States - Mexico Border Region Howard J. Eng, MS, DrPH Director, Southwest Border Rural Health.
Elizabeth WellsDennis Daley School of Social WorkWestern Psychiatric Institute University of WashingtonUniversity of Pittsbu rgh Supported by Grants #
Cancer Centers In Clinical Trials Sandrine Marreaud Head of Medical Department.
Why a CPCRN? CDC Expectations Katherine M. Wilson, PhD, MPH CPCRN Technical Monitor Division of Cancer Prevention and Control CDC.
Ann Bonham, PhD Chief Scientific Officer August 24, 2012 Methods, Metrics and Outcomes Evaluating the Success of Community Engaged Research.
“Community partnerships for better mental health and recovery” Advanced Care Directives Working Group Karen Blake Consumer & Carer Participation Officer.
A 2 DAHT provides evidence-based, unbiased, reliable and trusted health technology assessments and Education for a better global healthcare. Our results.
Lawrence B. Sadwin Friends of the World Heart Federation Foundation Moving Ahead: Leveraging Knowledge & Action to Improve Healthcare Quality. AHRQ 2012.
Sara Lovell, CPCS Education Coordinator Providence Alaska Medical Center.
Hiring a Nurse Researcher/Scientist Nursing Research Field Advisory Committee (NRFAC) January 2015.
Why Write A Grant? Elaine M. Hylek, MD, MPH Professor of Medicine Associate Director, Education and Training Division BU CTSI Section of General Internal.
Raise Awareness About National Standards for Health Literacy.
Serving Older Adults with Behavioral Health Needs January 11, Oregon Health Authority, Health Systems Division and Portland State University Institute.
Gaps in Substance Use Treatment Presented by: Rhonda G. Patrick, LCSW, MPA Amy C. Traylor, MSW, Ph.D.
Single Competency Framework for Prescribers National Prescribing Centre (2012)
EUNetPaS is a project supported by a grant from the EAHC. The sole responsibility for the content of this presentation lies with the author(s). The EAHC.
1 Maximizing the Impact of Comparative Effectiveness Research: The Role of the DEcIDE Consortia Scott R. Smith, PhD AHRQ Center for Outcomes & Evidence.
Component 1: Introduction to Health Care and Public Health in the U.S. 1.9: Unit 9: The evolution and reform of healthcare in the US 1.9c: Quality Indicators.
1 Center Mission Statements SAMHSA ? CSAT Improving the Health of the Nation by Bringing Effective Alcohol and Drug Treatment to Every Community CMHS Caring.
NHS Confederation Annual Conference 4 June Matching Health with Growth – the UHB Story.
Comparative Effectiveness Research (CER) and Patient- Centered Outcomes Research (PCOR) Presentation Developed for the Academy of Managed Care Pharmacy.
A Program of the Health Education Council Ayanna L. Kiburi, MPH Consultant.
OVERVIEW OF THE WORKFORCE DEVELOPMENT DOMAIN TASK FORCE APRIL 16, 2015 Joan D. Nagel, M.D., M.P.H. Program Director, Division of Clinical Innovation National.
Developing a guideline
Presentation Developed for the Academy of Managed Care Pharmacy
Dorota Kilańska RN, PhD European Nursing Research Foundation (ENRF)
WHO’s prioritised research agenda for the prevention and control of NCDs prioritises
NATIONAL outreach Network
Integrating Genetics & Genomics Education into Nursing Workforce
Musculoskeletal Health in Europe
Integrating Genetics & Genomics Education into Nursing Workforce
Presentation Developed for the Academy of Managed Care Pharmacy
ACTSI Presentation to MSCR Coloquium
High Value Care– What’s Needed?
Get Connected Knowledge Forum
Public/Population Health Approach to Substance Abuse Prevention & Treatment Determine the Burden of Substance Abuse and Service Barriers to Develop Plan.
Building PHN Scientists
Patient-Centered Outcomes Research Institute (PCORI)
Presentation Developed for the Academy of Managed Care Pharmacy
Presentation transcript:

Mt. Hood

IOM Report: 10 Years After & More Coming Mitch Greenlick, Ph.D. Oregon State Representative April 21, 2010

Bridging the Gap Between Practice and Research: Forging Partnerships with Community-Based Drug and Alcohol Treatment Sara Lamb, Merwyn Greenlick, and Dennis McCarty, Editors Institute of Medicine 1998

Findings and Recommendations Strategies for: – Linking research and practice – Linking research findings, policy development, and treatment implementation – Knowledge development – Dissemination and knowledge transfer – Consumer participation – Training for consumer-based research collaboration

The First Recommendation The National Institute on Drug Abuse and the Center for Substance Abuse Treatment should support the development of an infrastructure to facilitate research within a network of community-based treatment programs.

The Second Recommendation The National Institute on Drug Abuse and the National Institute on Alcohol Abuse should develop research initiatives to foster studies that include community-based treatment programs as full partners.

Issues Raised by Recommendation 2 Include treatment staff in the development of research initiatives and review of proposals Require assessment of burden of proposed research on treatment program and subjects Assess relevance and practicality for CBO implementation of proposed research Require active, early, and permanent participation of treatment staff in the development, implementation, and interpretation of research studies.

What Does the Future Hold Translational research: bench to bedside to community Community-participatory research Increased demand for evidenced-based practices by policy makers Comparative effectiveness research Increased recognition of the social costs of substance abuse.

Translational Research To improve human health, scientific discoveries must be translated into practical applications. Such discoveries typically begin at “the bench” with basic research — in which scientists study disease at a molecular or cellular level — then progress to the clinical level, or the patient's “bedside.”

Comparative Effectiveness Research Comparative effectiveness research is designed to inform health-care decisions by providing evidence on the effectiveness, benefits, and harms of different treatment options. The evidence is generated from research studies that compare drugs, medical devices, tests, surgeries, or ways to deliver health care

Steps Involved in Comparative Effectiveness Research Identify new and emerging clinical interventions. Review and synthesize current medical research. Identify gaps between existing medical research and the needs of clinical practice. Promote and generate new scientific evidence and analytic tools. Train and develop clinical researchers. Translate and disseminate research findings to diverse stakeholders. Reach out to stakeholders via a citizens forum.

Elements of the CTN Produce Perfect Setting to Move Forward Community participation in research Multicenter controlled-trial approach Potential for comparative effectiveness research Ability to move into policy transformation Trained researchers and research-trained treatment personal